Deadline: 27th February 2024
CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives. CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.
Successful applicants will receive funding of up to $400,000 USD over 2 years.
Interested researchers are invited to:
· Attend information webinars to learn more about the initiative:
· Contact Meghana Patel (email@example.com) and Anita Marguerie de Rotrou (firstname.lastname@example.org) to express interest in applying and to obtain online application submission instructions.
· Submit a non-confidential, 300-word abstract via the CSL online application portal by 27th February 2024.
Posted on 23/01/2024